| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TPIC | 59.75% | $45.86M | -76.49% | 0.00% |
| BB | 40.07% | $2.50B | +73.97% | 0.00% |
| CLW | 37.43% | $475.96M | -36.26% | 0.00% |
| FDMT | 36.52% | $195.49M | -81.40% | 0.00% |
| IDYA | 34.29% | $1.88B | -44.46% | 0.00% |
| CMTL | 34.19% | $74.08M | -16.83% | 0.00% |
| BEAM | 32.80% | $2.04B | -14.85% | 0.00% |
| HPP | 32.67% | $917.97M | -47.38% | 0.00% |
| LCID | 31.88% | $7.02B | -25.57% | 0.00% |
| AVO | 31.05% | $846.01M | +23.76% | 0.00% |
| SYRE | 30.75% | $942.12M | -42.27% | 0.00% |
| AAOI | 30.35% | $1.51B | +216.61% | 0.00% |
| AEIS | 30.27% | $5.20B | +28.88% | 0.29% |
| CELC | 30.12% | $507.41M | -21.73% | 0.00% |
| GBIO | 30.10% | $23.66M | -85.17% | 0.00% |
| TWST | 30.04% | $2.22B | -26.77% | 0.00% |
| GTLS | 29.99% | $7.52B | +24.00% | 0.00% |
| PGRE | 29.74% | $1.36B | +29.92% | 0.00% |
| UHAL.B | 29.47% | $10.95B | -2.38% | 0.36% |
| CGON | 29.32% | $1.98B | -19.15% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SPTN | -<0.01% | $898.36M | +47.53% | 3.30% |
| KDP | -0.01% | $46.22B | +6.51% | 2.71% |
| ACI | -0.02% | $12.50B | +13.93% | 2.44% |
| UL | -0.05% | $149.45B | +9.65% | 3.20% |
| CNR | -0.07% | $3.66B | -30.50% | 1.01% |
| LRN | -0.11% | $5.93B | +105.34% | 0.00% |
| VRSK | 0.12% | $42.32B | +9.86% | 0.56% |
| AWK | 0.12% | $27.50B | +7.88% | 2.23% |
| AQB | 0.14% | $3.01M | -53.91% | 0.00% |
| BF.A | 0.16% | $13.52B | -32.81% | 3.12% |
| HRL | -0.19% | $17.10B | +3.53% | 3.69% |
| CNK | 0.20% | $3.52B | +41.39% | 0.53% |
| RRGB | 0.24% | $112.98M | +4.43% | 0.00% |
| SKM | -0.25% | $8.45B | +6.67% | 4.81% |
| CAG | -0.30% | $9.86B | -28.15% | 6.76% |
| SWBI | -0.37% | $379.36M | -38.62% | 7.54% |
| ARDT | 0.38% | $1.97B | -13.94% | 0.00% |
| MO | -0.41% | $100.29B | +27.49% | 6.88% |
| TEF | -0.42% | $29.46B | +22.82% | 6.25% |
| SUZ | -0.44% | $11.53B | -0.99% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VCEB | 0.02% | $862.28M | 0.12% |
| IBDX | 0.06% | $1.16B | 0.1% |
| SPIB | -0.07% | $9.94B | 0.04% |
| BNDX | -0.09% | $67.61B | 0.07% |
| KBA | -0.10% | $176.69M | 0.56% |
| CTA | -0.14% | $1.06B | 0.76% |
| BSCW | -0.21% | $933.41M | 0.1% |
| BSMW | 0.23% | $107.54M | 0.18% |
| BSCU | -0.25% | $1.66B | 0.1% |
| FMB | 0.35% | $1.89B | 0.65% |
| IGOV | -0.36% | $1.23B | 0.35% |
| GRNB | -0.38% | $132.38M | 0.2% |
| IGIB | 0.38% | $15.44B | 0.04% |
| CGCP | -0.39% | $5.18B | 0.34% |
| USDU | 0.40% | $124.09M | 0.5% |
| SCHI | 0.48% | $8.68B | 0.03% |
| XBIL | 0.49% | $784.40M | 0.15% |
| VMBS | -0.52% | $14.36B | 0.03% |
| KCCA | 0.55% | $108.82M | 0.87% |
| NUAG | 0.59% | $58.50M | 0.19% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| IIPR | -19.65% | $1.55B | -48.63% | 13.59% |
| CBOE | -19.01% | $24.35B | +37.95% | 1.09% |
| PPC | -14.21% | $10.85B | +36.15% | 0.00% |
| CL | -12.30% | $74.67B | -5.05% | 2.19% |
| GALT | -11.99% | $132.28M | -11.81% | 0.00% |
| EXC | -9.06% | $43.41B | +24.89% | 3.62% |
| SCHL | -9.04% | $570.22M | -39.68% | 3.73% |
| NVO | -8.18% | $234.42B | -50.41% | 2.41% |
| MESO | -7.96% | $1.33B | +37.59% | 0.00% |
| RGR | -7.91% | $599.29M | -11.49% | 1.99% |
| GPK | -7.66% | $6.66B | -12.90% | 1.90% |
| CME | -7.48% | $99.33B | +45.14% | 1.75% |
| LITB | -7.20% | $23.17M | -74.54% | 0.00% |
| VZ | -6.63% | $181.55B | +4.26% | 6.29% |
| VHC | -6.28% | $57.60M | +131.12% | 0.00% |
| CHT | -6.12% | $34.39B | +22.73% | 3.76% |
| RUM | -6.04% | $3.04B | +59.79% | 0.00% |
| PDD | -5.91% | $147.64B | -22.81% | 0.00% |
| OHI | -5.78% | $10.50B | +8.17% | 7.36% |
| HTO | -5.65% | $1.77B | -4.20% | 3.13% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -30.82% | $185.99M | 0.85% |
| BTAL | -26.34% | $312.42M | 1.43% |
| TAIL | -21.54% | $95.09M | 0.59% |
| CARY | -18.52% | $347.36M | 0.8% |
| XONE | -14.73% | $627.68M | 0.03% |
| SCHO | -13.86% | $11.00B | 0.03% |
| UTWO | -13.68% | $376.38M | 0.15% |
| SHY | -13.42% | $23.60B | 0.15% |
| IBTH | -13.05% | $1.61B | 0.07% |
| VGSH | -12.82% | $22.64B | 0.03% |
| SPTS | -11.81% | $5.77B | 0.03% |
| IEI | -10.97% | $15.58B | 0.15% |
| YEAR | -10.50% | $1.47B | 0.25% |
| IVOL | -10.31% | $342.02M | 1.02% |
| FLGV | -10.31% | $1.02B | 0.09% |
| AGZ | -9.99% | $610.34M | 0.2% |
| IBTM | -9.87% | $315.31M | 0.07% |
| IBTJ | -9.79% | $682.49M | 0.07% |
| BSV | -9.67% | $37.94B | 0.03% |
| IBTL | -9.58% | $380.15M | 0.07% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IWC | 33.76% | $847.74M | 0.6% |
| XBI | 33.29% | $4.90B | 0.35% |
| ARKG | 32.85% | $1.06B | 0.75% |
| PBW | 32.46% | $293.05M | 0.65% |
| GNOM | 31.22% | $46.32M | 0.5% |
| IWO | 30.73% | $11.87B | 0.24% |
| RYLD | 30.43% | $1.30B | 0.6% |
| QTUM | 30.30% | $1.66B | 0.4% |
| PTH | 30.22% | $97.73M | 0.6% |
| KJAN | 29.95% | $287.30M | 0.79% |
| BSJP | 29.76% | $849.79M | 0.43% |
| CWB | 29.62% | $3.92B | 0.4% |
| IWMY | 29.54% | $121.39M | 1.02% |
| IWM | 29.52% | $66.85B | 0.19% |
| VTWO | 29.47% | $12.85B | 0.07% |
| ARKX | 29.33% | $338.11M | 0.75% |
| IBB | 28.95% | $5.44B | 0.45% |
| KOMP | 28.91% | $2.35B | 0.2% |
| HEAL | 28.89% | $43.43M | 0.5% |
| QCLN | 28.80% | $422.30M | 0.56% |
Finnhub
Presenter SpeechRobert Burns Hello. I'm Robert Burns, Managing Director and Senior Biotech Analyst at H.C. Wainwright. And I'm joined today by Dave Lennon and Dave Dornan, President and CSO of --...
Finnhub
MORRISTOWN - Whitehawk Therapeutics, Inc. , an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments,...
Yahoo
Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, announced today that Dave Lennon, PhD, President and CEO, and David Dornan, PhD, Chief Scientific Officer, will participate in the virtual H.C. Wainwright "HCW@Home" series on Thursday, June 26, 2025, at 10 AM ET.
Finnhub
Corporate Presentation June 2025 ...
Yahoo
Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, announced today its presentation at the Jefferies 2025 Global Healthcare Conference, taking place June 3-5, 2025, in New York City, NY. Dave Lennon, PhD, President and CEO, will present a company overview on Wednesday, June 4, 2025, from 2:00-2:30 PM ET.
Yahoo
Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, announced today the Company's president and CEO, Dave Lennon, PhD, will participate in a fireside chat at the TD Cowen 6th Annual Oncology Innovation Summit: Insights for ASCO & EHA, on May 28, 2025, at 2:30 PM ET.
Current Value
$1.991 Year Return
Current Value
$1.991 Year Return
